Back to Authors

Dudley, Matthew W.

A5112329019 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 1

53BP1 as a predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5538-5538

10.1200/jco.2018.36.15_suppl.5538